Suppr超能文献

葡萄膜黑色素瘤氦离子放射治疗后的眼前段并发症。放射性白内障。

Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract.

作者信息

Meecham W J, Char D H, Kroll S, Castro J R, Blakely E A

机构信息

Department of Ophthalmology, University of California, San Francisco.

出版信息

Arch Ophthalmol. 1994 Feb;112(2):197-203. doi: 10.1001/archopht.1994.01090140073026.

Abstract

OBJECTIVE

To delineate the factors in the development of visually significant cataract after helium ion irradiation of eyes with uveal melanomas.

DESIGN

Retrospective analysis with multivariate analysis using life tables and Cox proportional hazard models in addition to other nonparametric techniques.

PATIENTS

All patients with a noncataractous other eye and adequate dosimetry data who were treated with helium ion irradiation.

RESULTS

Significant cataracts (grade 3+ or 4+ on a 0 to 4+ scale) developed in 129 patients (44%). The risk of cataract development peaked at 3 years (25% per person-year) and then declined to a sustained level of 7% to 9% per year after 7 years. In multivariate analysis, the percentage of lens included in the treatment port was the predominant predictive correlate with time to significant cataract (relative risk of 2.97 for a 25% increase in the percentage of lens in the treatment port). Patient age, preexisting cortical opacity, and ultrasound tumor height were also significant; ciliary body involvement and tumor dose had smaller effects. Kaplan-Meier analysis demonstrated an increased rate of cataractogenesis with each increment of the percentage of lens in the treatment port; when more than half of the lens was in the beam, the risk of cataract exceeded 90% within 7 years.

CONCLUSIONS

Cataract development after helium ion irradiation is a function of the amount of the lens in the beam. Unlike neovascular glaucoma that develops mainly in the first few years after treatment, cataract continues to develop during the entire length of follow-up.

摘要

目的

明确葡萄膜黑色素瘤眼经氦离子照射后发生具有明显视觉影响的白内障的相关因素。

设计

采用回顾性分析,并运用生命表和Cox比例风险模型进行多变量分析,同时结合其他非参数技术。

患者

所有接受氦离子照射且对侧眼无白内障且有足够剂量测定数据的患者。

结果

129例患者(44%)发生了明显白内障(0至4 +分级为3 +或4 +级)。白内障发生风险在3年时达到峰值(每人年25%),7年后降至每年7%至9%的持续水平。在多变量分析中,治疗野内晶状体包含的百分比是与明显白内障发生时间的主要预测相关因素(治疗野内晶状体百分比增加25%时,相对风险为2.97)。患者年龄、既往皮质混浊和超声肿瘤高度也具有显著意义;睫状体受累和肿瘤剂量的影响较小。Kaplan - Meier分析表明,随着治疗野内晶状体百分比的每一次增加,白内障发生率升高;当超过一半的晶状体位于射野内时,7年内白内障风险超过90%。

结论

氦离子照射后白内障的发生取决于射野内晶状体的量。与主要在治疗后最初几年发生的新生血管性青光眼不同,白内障在整个随访期间持续发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验